inflammatory bowel disease(ibd)-ulcerative colitis and crohn’s

68
Inflammatory bowel disease(IBD)- ulcerative colitis and Crohn’s alterations in microbiome play a role in IBD 1)different oxidative pathways in the altered microbiome 2)more aggressive nutrient uptake by altered microbiome-this favours the altered microbiome 3) altered microbiome is more

Upload: oriel

Post on 14-Jan-2016

37 views

Category:

Documents


0 download

DESCRIPTION

Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s alterations in microbiome play a role in IBD 1)different oxidative pathways in the altered microbiome 2)more aggressive nutrient uptake by altered microbiome-this favours the altered microbiome - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

alterations in microbiome play a role in IBD1)different oxidative pathways in the altered microbiome

2)more aggressive nutrient uptake by altered microbiome-this favours the altered microbiome

3) altered microbiome is more virulent

Page 2: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Exam

180 minutes

120 multiple choice questions-120 points-4 short answer question-60 points

multiple choice-lecture 7a-12c inclusiveshort answer-whole Nutr2105 course

Page 3: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

NoteNutrition 2106-Fall 2014- Principles of Nutrition in Metabolism

Nutrition 2101-Nutritional Assessment-Theory-Fall 2014

Nutrition 2107- Introduction to Sports Nutrition-Winter 2015

Page 4: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Note

Nova Scotia now spends 47 cents of every budgetdollar on healthcare(10 years ago it was 40 cents)-is the publically funded healthcare system in its present form sustainable?

Page 5: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Note

Email sent today to first year and senior students.

Email is regarding completion of NSEE survey (first year and senior students)

. Please complete to help CBU better help you!

Page 6: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s
Page 7: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Lecture 10a

17 March 2014 Enteral and Parenteral Feeding

Page 8: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Enteral Feeding -refers to use of intestine (uses oral or tube feeding to direct nutrients to intestine) -called complete enteral feeding if formula is primary source of nutrients -complete formulas can be used in smaller quantities to supplement table foods -complete formulas required if patient is on tube feeding or oral liquid diet for more than a few days

Page 9: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Types of enteral formulations

-standardised

-hydrolysed

-modular

-characterised by type of protein in the formulation

Page 10: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Types of enteral formulationsStandardised Appropriate for people who are able to digest and absorb Contain complete proteins (complete refers to whole proteins or combination of protein isolates(purified proteins)) Blenderised formulas contain protein from pureed foods (e.g. blenderised meats)

Page 11: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Types of enteral formulations

Hydrolysed • Pre-digested protein- so only get small

peptides or just free amino acids • Some have medium chain triglycerides or are

very low in fat

Page 12: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Types of enteral formulation

Modular Provide a single nutrient Modules can be combined with other modules or with minerals and/or vitamins to address the specific needs of a patient

Page 13: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Candidates for tube feeding

Anybody who:

•can not get food down orally or •has mental incapacitation•are malnourished or •has high nutrient requirements or extensive intestinal resections or is on a ventilator•gastrointestinal obstructions or fistulas

•in short anyone who cannot access or utilise GI tract on their own

Page 14: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Distinguishing characteristics of enteral formulations 1)Nutrient density

1.0  kcal/ml- standard

1.2 – 2.0 kcal/ml for nutrient dense formulas -nutrient dense formulations are given in

smaller volumes to persons with fluidbalance issue- e.g. congestive heart patients

Page 15: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Distinguishing characteristics of enteral formulations

2) Fibre if administered over short time - low to moderate fibre - otherwise gas and distension can be an issue if long term administration -then higher amounts of fibre

Page 16: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Distinguishing characteristics of enteral formulations

3) Osmolality- measure of concentration of molecular and ionic particles in solution

-serum is 300 milliosmoles/kg of solution -isotonic solution is 300 milliosmoles/kg -hypertonic is greater than 300

milliosmoles/kg of solution -hypertonic can induce diarrhea in

intestine so a slow introduction of hypertonic solution for

intestinal route is essential

 

Page 17: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Tube placement-1) transnasal or 2) direct catheter 1)Transnasal

Nasogastric-children and adults-larger nose than infants so nasogastric is used in children and adults

Orogastric-infants- smaller nose than adults and children so orogastric is used

 Nasoduodenal-nose to duodenum

 Nasojejunal placement-nose to jejunum

 

Page 18: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Tube placement

2) Catheter direct to stomach or jejunum

Enterostomies- surgical placement of catheter  

-Gastrostomy- direct to stomach 

-Jejunostomy-direct to jejunum

Page 19: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s
Page 20: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s
Page 21: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Safehandling of formulations 

Open and closed systems 

Open- exposed to air 

Closed-not exposed to air 

Keep your fingers out of the soup for opensystems

Page 22: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Initiating and progressing a tube feeding Formula delivery techniques-Intermittent feeding  •Best to stomach•No more than 250-400 ml over 30 minutes•Use- depends on tolerance Bolus feeding included here (300-400 ml) in 10 minutes 

Page 23: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Initiating and progressing a tube feeding  Formula delivery techniques

Continuous feedingDelivered slowly over 8-24 hours

 Good for people who have received nothing though GI tract for a long time, hypermetabolising persons and those

receiving intestinal feedings 

Formula volume and strengthinstitutionally based- standard operating procedures (sops)

 

Page 24: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Initiating and progressing a tube feeding  Additional matters

Supplemental water-standard formulas contain about

850 ml of water/per formula-most people need about 2 L of

water per day 

Gastric residual volume-amount left over from previous

feedings-significance of this?

Page 25: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

2 Youtubes- enteral feeding

https://www.youtube.com/watch?v=EWtqxJeyCMA https://www.youtube.com/watch?v=hploKHe-V4U

Page 26: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Class activity

Design an enteral feeding for the pathology/problem of your choice that meets the dietary principles of adequacy, variety, moderation, nutrient density, energy control, and balance

Page 27: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Lecture 10b

17 March 2014 Parenteral Feeding

Page 28: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Parenteral Feeding (going around ie circumventing the intestine)Nutrients go directly into blood stream bypassing gastrointestinal tract-this is done by intravenous needle or catheter

Used when a patient cannot, due to physical or psychological impairment, consume sufficient nutrients enterally Used when patients gi system will not adequately process food for body 

Actual infusion depends on site of infusion and patient’s fluid and nutrient requirements

Page 29: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Types of Parenteral Nutrition 

Peripheral parenteral nutrition (PPN)-peripheral vein used

 Total parenteral nutrition (TPN)-superior vena cava used

 Basic difference between the two is the

concentration of nutrients infused (higher concentration is used for TPN due to more rapid dilution in superior vena cava) 

Page 30: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Parenteral Feeding

Usual fluid volume is 1.5-2.5 L over a 24 hour period for most people 

Page 31: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Parenteral Feeding

Composition of ingredients in bag for intravenousdelivery

DextroseAmino acidsLipid emulsionSterile waterElectrolytesVitamins

Page 32: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Carbohydrate 

Dextrose- provides 3.4 kcal/g and not 4 kcal/g-difference is due to what?

 Concentration is 12.5 % (max for peripheral introduction) to 25 % (total parenteral

nutrition) 

Restricted in ventilator patients because oxidation of glucose produces more carbon dioxide than does oxidation of fat

Page 33: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Protein 

Mixture of essential and non-essential amino acids

 Concentration 3.5-15 %

 Quantity of amino acids depends on patients estimated requirements and hepatic and renal function-why?

Page 34: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Lipid emulsions 

Safflower and soybean oil with egg lecithin used as an emulsifier (why the emulsifier and how does it work?)

 Isotonic

 Significant source of calories

Page 35: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Lipid emulsionsAvailable in 10, 20, 30 % concentrations

supplying 0.9 and 1.8 and 2.7 kcal/ml respectively-Do the math 

Usual dose is 0.5 to 1 g/kg/day to supply 20-30 % of total kcal requirement

 IV fat contradicted for severe hepatic

pathology, hyperlipidemia or severe egg allergies 

Used cautiously with atherosclerosis, blood coagulation disorders

Page 36: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Electrolytes 

Dictated by patients blood chemistry values and physical assessment findings

 

Page 37: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Standard multivitamin and trace mineral preparations added to parenteral solutions to meet micronutrient needs 

Page 38: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

PPN

-must be isotonic and therefore low in dextrose and amino acids to prevent phlebitis and increased risk of thrombus formation 

-need to maintain isotonic solutions of dextrose and amino acids while avoiding fluid overload limits the caloric and nutritional value of PPN 

Page 39: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

PPN  delivers complete but limited nutrition the final concentration cannot exceed 12.5 % dextrose-also uses lower concentrations of amino acids vitamins and minerals are added lipid emulsion may be added to supplement calories depending on the patients tolerance

Page 40: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

PPN

-provides temporary nutritional support -short term- 7-10 days and do not require more than 2000 to 2500 kcal per day

Page 41: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

PPN

-may be used for a post surgical ileus or anastomotic leak or for patients who require nutritional support but are unable to use TPN because of limited accessibility to a central vein -sometimes used to supplement an oral diet or tube feeding or transition from TPN to enteral intake 

Page 42: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

TPN

Hypertonic solutions provide more dextrose and/or protein but they must be delivered centrally in a large diameter vein so that they can be quickly diluted 

Page 43: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

TPN

 TPN is used when nutritional requirements are high and anticipated need is relatively long3 litres of 10 % dextrose provides only 1020 kcal

-calculation  

Page 44: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

TPN

-traditionally-catheter to superior vena cavafigure 21-2

   

Page 45: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

TPNIndications:

severe malnutrition

GI abnormalities : due to obstruction, peritonitis, severe acute pancreatitis

after surgery or trauma especially that involving extensive burns, sepsis

need for supplementation of inadequate oral uptake in patients who are being treated aggressively for cancer

bone marrow transplantation

Page 46: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

TPN cyclic

-constant infusion for 8-12 hours-used for home patients-used to support inadequate oral

intake -allows insulin and glucose to drop

when infusion is not taking place

 -switch from continuous TPN to cyclic TPN should be gradually decreased by several hours per day and signs of glucose overload and fluid imbalance should be monitored

Page 47: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Note

Page 48: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Lecture 10c

17 March 2014

Surgery and Burns  

Page 49: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Surgery 

-patient should be well nourished prior to surgery-this gives better recovery

  -however, surgical patients are often

malnourished due to anorexia, nausea, vomiting, burns, fever, malabsorption, and blood loss

  -surgical prep- range of actions include:

-high calorie protein diet -enteral feeding -parenteral feeding

Page 50: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Surgery

-nothing by mouth (NPO) for a least 8 hours prior to general anesthesia due to risk of aspiration

  -oral intake is resumed after bowel sounds

return- usually 24-48 hours after surgery 

-start with clear liquids to full liquids to soft or regular diet as tolerated post-op

 -usually a high protein high calorie diet is

appropriate-this helps with healing

Page 51: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Burns 

-hypermetabolism involved- why?  

-large quantities of nutrients leech through burn area

 -therefore fluid and electrolyte imbalances are a problem

Page 52: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Burns

-result in anorexia, pain, emotional trauma, weight loss and immune incompetence, malnutrition

   

Page 53: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Burns

-after fluid and electrolytes are addressed and by hour 72 (if bowel sounds)- oral intake begins -if no bowel sounds by hour 96 then PPN or TPN

Page 54: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Burns- regardless of routes of administration 

-Protein 1.5-3.0 g /kg body weight/day 20-25 % protein, 50 % carbohydrate, 25 % fat

-Kcal- additional 40-60 kcal/kg body weight/day

 

-high fluid intake –including more potassium, zinc and vitamins A and C (zinc, vitamins A and C for wound healing) and vitamins B1, B2

and B3 (in proportion to increased energy

intake)

Page 55: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Table 29-1, p. 870

Page 56: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Table 29-2, p. 903

Page 57: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Table 29-3, p. 904

Page 58: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

CancerDietary factors - cancer initiators

- these dietary components start cancer

 -additives and pesticides are of particular but not exclusive concern here  -stomach cancer particularly high in parts of world where pickled or salt-cured foods that produce carcinogenic nitrosamines are consumed

Page 59: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

CancerDietary factors

-alcohol associated with high incidence of some cancers, especially of the mouth, esophagus and liver in all persons and breast cancer(post-

menopausal) in females

-beer and scotch may contain nitrosamines-wine and brandy may contain urethane-urethane and nitrosamines are carcinogens-moderation is the key to prevention here

Page 60: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

 Dietary factors –cancer promoters and inhibitors

-cancer promoters accelerate the rate of progression of cancer once it has started

 - eg excess dietary fats -linoleic acid- has been suggested to

promote 

-omega 3s have been suggested to prevent or delay cancer development

Page 61: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

 Dietary factors-antipromoters Fruits and veggies as per Canada’s food guide

-fibre speeds up gi transit time thus reducing carcinogen exposure 

-fruits and vegetables containing antioxidants that scavenge free radicals –such free radicals contribute to cancer 

-various phytochemicals activate enzymes that can destroy carcinogens

Page 62: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

Once cancer starts -do nutritional assessment and respond accordingly -early dietary intervention prepares body for

stresses that lay ahead 

Page 63: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

 AIDS 

Weight loss, diarrhea, seborrhea, eczema, fever, sweating-nutritional implications?

Nutritional implications can further deteriorate patient’s health e.g. further immune response compromise

Kcal requirement is increased compared to non-infected persons in good health

Protein requirements 1-2 g/kg bw/day due to lean body mass loss and other protein losses

Page 64: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

 AIDS 

Drugs can exacerbate nutritional difficulties (table)

Page 65: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s
Page 66: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

AIDS

Fat

– medium chain triglycerides(mct) (6-12 carbon fatty acids) for additional calories

-lipase and bile not required for mct- therefore easier absorption

Page 67: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

AIDS

Vitamins and Minerals

recommendation-close to DRI-otherwise adverse interactions with antiretroviral drugs

Page 68: Inflammatory bowel disease(IBD)-ulcerative colitis and Crohn’s

AIDS Feedings

-small, numerous meals

-liquid commercial preparations

-antidiarrheals shortly before meals

-high soluble fibre foods like oatmeal, cooked carrots, bananas, peeled apples and apple sauce may help slow transit time (diarrhea reduced perhaps)